Understanding cachexia in patients with cancer
Intended for healthcare professionals
CPD Previous     Next

Understanding cachexia in patients with cancer

Susan Holmes Director of research and development, Faculty of Health and Social Care, Canterbury Christ Church University, Kent

Cancer cachexia is a progressive wasting syndrome characterised by loss of both adipose tissue and lean body mass. It is a complex metabolic process common in patients with cancer and responsible for death. Consideration of this syndrome is important because of its prevalence and its significant effect on morbidity, mortality and nutritional and psychological status.

Nursing Standard. 25, 21, 47-56. doi: 10.7748/ns2011.01.25.21.47.c8290

Correspondence

susan.holmes@canterbury.ac.uk

Peer review

This article has been subject to double blind peer review

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more